Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Alzheimer’s Disease Clinical Trial Read more
Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine Read more
Dupixent (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis Read more
Exclusive interview with conference speaker Che Connon released ahead of SMi’s Ophthalmic Drugs Conference Read more